Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Protein Profiling Assays Diagnose Periprosthetic Joint Infection

By LabMedica International staff writers
Posted on 05 Oct 2011
Molecular markers found in the protein in synovial fluid may aid in the diagnosis of patients undergoing revision arthroplasty for septic or aseptic failure. More...


Proteomic analysis has the potential as highly sensitive diagnostic tool for periprosthetic joint infection (PJI) that occur during surgical reconstruction or replacement of a malformed or degenerated joint.

Doctors at the Thomas Jefferson University Hospital (Philadelphia, PA, USA) collected synovial fluid specimens from selected patients in the operating room at the time of revision surgery and before incision into the joint (arthrotomy). Samples were assayed to determine the concentration of inflammatory proteins according to MultiAnalyte profiling (MAP) protocols established by Rules-Based Medicine (RBM; Austin, TX, USA). The samples were shipped to RBM for Human Inflammation MAP analysis, which quantifies concentrations of 46 inflammatory proteins in fluid samples using a multiplex enzyme-linked immunosorbent assay (ELISA) protocol.

The scientists analyzed 74 synovial fluid samples: 31 infected and 43 uninfected, based on clinical and laboratory criteria. Proteomics analysis and receiver operating characteristic curve analyses were conducted on 46 inflammatory proteins for each sample. Of the 46 proteins, 5 including interleukin 6, interleukin 8, alpha (2)-macroglobulin, C-reactive protein, and vascular endothelial growth factor had an area under the curve greater than 0.90, indicating their importance in infected joints. Of the infected cases, purulence was identified intraoperatively in 22 cases, and an organism was isolated preoperatively or intraoperatively in 16 cases. The organisms isolated included primarily Staphylococcus and Streptococcus species.

The study demonstrated that inflammatory proteins can be detected in synovial fluid and their concentrations ascertained, and these varying concentrations align well with the presence or absence of PJI. The study was published in September 2011, in the Journal of Arthroplasty.

Related Links:
Thomas Jefferson University Hospital
Rules-Based Medicine




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.